Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA launches new priority review voucher program for select biopharmas
AI and Machine Learning
MedTech
Caris Life Sciences ups IPO to raise $494M
The cancer testing company claimed a valuation of about $5.9 billion, while selling 23.5 million shares under the Nasdaq ticker "CAI" at $21 apiece.
Conor Hale
Jun 18, 2025 11:00am
Philips unveils new portable ultrasound system for critical care
Jun 17, 2025 1:03pm
FDA hopes AI can deliver 'rapid or instant' reviews
Jun 11, 2025 12:45pm
'The opportunities are immense': Novo to use supercomputer
Jun 11, 2025 8:35am
Recursion lays off 20% of staff in wake of pipeline cutbacks
Jun 10, 2025 9:25am
Caris Life Sciences to go public in $400M Nasdaq IPO
Jun 9, 2025 10:30am
